| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
26,333 |
23,106 |
$703K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,372 |
14,784 |
$378K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,037 |
1,922 |
$63K |
| 99350 |
Prolong home eval add 15m |
1,210 |
995 |
$40K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,822 |
4,035 |
$29K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,441 |
1,166 |
$26K |
| 99000 |
|
2,078 |
1,948 |
$20K |
| 90674 |
|
2,177 |
2,103 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,102 |
1,045 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,791 |
3,584 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,887 |
1,826 |
$7K |
| 82947 |
|
9,788 |
8,324 |
$7K |
| 99442 |
|
368 |
316 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
588 |
562 |
$6K |
| 90756 |
|
483 |
473 |
$5K |
| 99349 |
|
315 |
289 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
141 |
128 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
54 |
54 |
$2K |
| 99091 |
|
148 |
148 |
$2K |
| 0011A |
|
168 |
165 |
$2K |
| 0012A |
|
162 |
161 |
$2K |
| 99490 |
Ccm add 20min |
1,069 |
1,069 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
18 |
16 |
$1K |
| 81003 |
|
1,721 |
1,563 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
12 |
12 |
$817.25 |
| 99443 |
|
35 |
32 |
$799.90 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
14 |
$685.24 |
| 90661 |
|
34 |
32 |
$678.60 |
| 99215 |
Prolong outpt/office vis |
29 |
27 |
$599.33 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
1,662 |
1,628 |
$378.29 |
| 99441 |
|
41 |
39 |
$366.99 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
583 |
533 |
$358.85 |
| 82044 |
|
361 |
348 |
$336.69 |
| 82570 |
|
328 |
315 |
$301.55 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
41 |
29 |
$290.08 |
| 0064A |
|
27 |
27 |
$160.00 |
| 93922 |
|
60 |
59 |
$146.24 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
2,259 |
2,167 |
$110.65 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
183 |
170 |
$91.84 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
19 |
12 |
$54.64 |
| G0008 |
Administration of influenza virus vaccine |
1,718 |
1,679 |
$49.15 |
| 36415 |
Collection of venous blood by venipuncture |
3,080 |
2,855 |
$26.75 |
| 93000 |
|
16 |
15 |
$24.46 |
| 90686 |
|
16 |
15 |
$20.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
2,481 |
2,351 |
$11.30 |
| 81001 |
|
104 |
103 |
$7.98 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
93 |
90 |
$0.02 |
| 2000F |
|
43,124 |
36,446 |
$0.01 |
| 1125F |
|
13,142 |
11,668 |
$0.01 |
| 3079F |
|
5,441 |
4,931 |
$0.01 |
| 3075F |
|
4,054 |
3,661 |
$0.01 |
| 0521F |
|
8,097 |
7,194 |
$0.01 |
| 1160F |
|
18,411 |
15,761 |
$0.01 |
| 1159F |
|
18,456 |
15,794 |
$0.01 |
| 1126F |
|
10,025 |
9,048 |
$0.00 |
| 1036F |
|
5,231 |
4,744 |
$0.00 |
| 1101F |
|
1,479 |
1,417 |
$0.00 |
| 3074F |
|
13,233 |
11,571 |
$0.00 |
| 91301 |
|
396 |
392 |
$0.00 |
| 1170F |
|
1,269 |
1,216 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
241 |
229 |
$0.00 |
| 3008F |
|
2,330 |
2,088 |
$0.00 |
| 1220F |
|
240 |
234 |
$0.00 |
| 3048F |
|
71 |
67 |
$0.00 |
| 1030F |
|
177 |
160 |
$0.00 |
| 4037F |
|
760 |
725 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
124 |
114 |
$0.00 |
| 1111F |
|
303 |
283 |
$0.00 |
| 1000F |
|
1,301 |
1,139 |
$0.00 |
| 96127 |
|
302 |
283 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
130 |
117 |
$0.00 |
| 3044F |
|
134 |
130 |
$0.00 |
| G8473 |
Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed |
206 |
190 |
$0.00 |
| G8410 |
Footwear evaluation performed and documented |
17 |
16 |
$0.00 |
| 0509F |
|
24 |
24 |
$0.00 |
| G8542 |
Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required |
14 |
14 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$0.00 |
| 91306 |
|
25 |
25 |
$0.00 |
| 3080F |
|
56 |
50 |
$0.00 |
| 3060F |
|
12 |
12 |
$0.00 |
| 3011F |
|
25 |
25 |
$0.00 |
| 4010F |
|
13 |
13 |
$0.00 |
| 3078F |
|
11,959 |
10,478 |
$0.00 |
| 3288F |
|
1,835 |
1,749 |
$0.00 |
| G8421 |
Bmi not documented and no reason is given |
684 |
570 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
6,211 |
5,589 |
$0.00 |
| 3077F |
|
175 |
156 |
$0.00 |
| 1090F |
|
323 |
309 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
250 |
232 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
239 |
211 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
12 |
12 |
$0.00 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
12 |
12 |
$0.00 |
| 4013F |
|
121 |
104 |
$0.00 |
| 90662 |
|
54 |
53 |
$0.00 |
| 99173 |
|
15 |
14 |
$0.00 |
| 0013A |
|
13 |
13 |
$0.00 |
| 3725F |
|
14 |
13 |
$0.00 |
| 3045F |
|
12 |
12 |
$0.00 |